| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 10/04/2006 | CN1839788A Immune globulin G biological factor oral detergent |
| 10/04/2006 | CN1277926C Hepatitis B virus gene siRNA sequence and its use |
| 10/04/2006 | CN1277840C Growth hormone releasing compound for treating tumor and inhibitor thereof |
| 10/04/2006 | CN1277828C Piperzine derivative |
| 10/04/2006 | CN1277824C Piperazine derivatives |
| 10/04/2006 | CN1277822C Quinazoline derivatives, pharmaceutical composition containing the compound, their utilization and preparation method thereof |
| 10/04/2006 | CN1277580C Use of chemical synthetic antifungal disome peptide for treating pathogenic fungus infection |
| 10/04/2006 | CN1277573C Medication for curing ulcer of oral cavity |
| 10/04/2006 | CN1277572C Medicinal composition for treating ulcerative colitis and its preparing method |
| 10/04/2006 | CN1277571C Chinese medicine preparation for stomach diseases |
| 10/04/2006 | CN1277570C Pharmaceutical for treating alimentary tract ulcer disease and preparing process thereof |
| 10/04/2006 | CN1277563C Traditional Chinese medicine composition for treating calculi |
| 10/04/2006 | CN1277561C Disinfecting tumour-decomposition powder |
| 10/04/2006 | CN1277558C Chinese traditional medicine preparation for treating chronic enteritis, colitis and proctitis |
| 10/04/2006 | CN1277547C New use of cimicifuga root and its effective part, monomer in treating hepatitis B and its preparation method |
| 10/04/2006 | CN1277546C Chinese medicine extract for treating fatty liver, obesity and its preparation method |
| 10/04/2006 | CN1277543C Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses |
| 10/04/2006 | CN1277539C Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives |
| 10/04/2006 | CN1277538C Matrine drop pills and its preparation method |
| 10/03/2006 | US7115780 For therapy of ulcers, pancreatitis, obesity, urinary incontinence and pollakiuria |
| 10/03/2006 | US7115768 Particularly (adamantylcarbonylamino)acetic acid derivatives |
| 10/03/2006 | US7115752 Substituted cyclic compounds |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115723 Humanized antibody specific for surface antigen pre-S1 of HBV and preparation method thereof |
| 10/03/2006 | US7115637 Inhibitors of p38 |
| 10/03/2006 | US7115635 Benzylpiperidine compound |
| 10/03/2006 | US7115633 Benzosuberonylpiperdine compounds as analgesics |
| 10/03/2006 | US7115629 Carbamates derived from arylalkylamines |
| 10/03/2006 | US7115623 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 10/03/2006 | US7115615 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; derivatives of 4-(1,3-benzo-dioxol-4-yl)amino-)quinazoline |
| 10/03/2006 | US7115585 Compositions for treating epithelial and retinal tissue diseases |
| 10/03/2006 | US7115560 of given amino acid sequence, for reducing gastric acid or pepsinogen secretion |
| 10/03/2006 | US7115395 DNAs encoding guinea pig histamine receptors of the H4 subtype |
| 10/03/2006 | US7115252 For restoration and maintenance of gingival and periodontal health; antiplaque/antitar agents; mouthwash |
| 10/03/2006 | CA2346438C Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases |
| 10/03/2006 | CA2215319C Compositions comprising nicotinylalanine and an inhibitor of glycine conjugation or vitamin b6 |
| 10/03/2006 | CA2189221C Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/28/2006 | WO2006102112A2 Prokineticin 1 receptor |
| 09/28/2006 | WO2006101818A1 Antibacterial 3',5-disubstituted 2,4'-dihydroxybiphenyl compounds, derivatives and related methods |
| 09/28/2006 | WO2006101434A1 NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1’ RECEPTOR LIGANDS |
| 09/28/2006 | WO2006101244A2 Method and composition for treating mucosal disorders |
| 09/28/2006 | WO2006101181A1 Composition for prevention or improvement of liver dysfunction, and method for preventing or improving liver dysfunction |
| 09/28/2006 | WO2006100392A1 Novel use of tritoqualine for treating digestive inflammatory diseases and more particularly gastric and esophageal diseases |
| 09/28/2006 | WO2006100255A1 Thioamide-substituted tricyclic benzimidazoles useful for the treatment of gastrointestinal diseases |
| 09/28/2006 | WO2006100254A1 6-thioamide substituted benzimidazoles |
| 09/28/2006 | WO2006100243A1 Process for the preparation of pantoprazole |
| 09/28/2006 | WO2006100204A1 Benzamidine derivatives for treatment and prevention of cancer therapy induced mucositis |
| 09/28/2006 | WO2006100195A1 Use of macrolides for treating intestinal inflammation |
| 09/28/2006 | WO2006100119A1 Derivatives of imidazo (1,2-a) pyridine useful as medicaments for treating gastrointestinal diseases |
| 09/28/2006 | WO2006099810A1 Substituted sulfoxide compounds, methods for preparing the same and use thereof |
| 09/28/2006 | WO2006068485A3 Temporally meal menu for infants |
| 09/28/2006 | WO2006045319A3 Uses of growth hormone secretagogues in the treatment of individuals suffering from renal and/or liver failure |
| 09/28/2006 | WO2006028810A3 Method of wound healing using a2b adenosine receptor antagonists |
| 09/28/2006 | WO2005118567A3 Magnesium complexes of s-omeprazole |
| 09/28/2006 | WO2005021776A3 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF |
| 09/28/2006 | US20060217536 Monoclonal antibody that has an extremely high binding ability to human ZAQL-1 and can neutralize or inhibit its activity, useful for diagnosing, preventing and treating endometrial cancer, endometriosis or ovulation disorders. |
| 09/28/2006 | US20060217531 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 09/28/2006 | US20060217530 Active against C5a receptors on polymorphonuclear leukocytes and macrophages; peptidomimetics; for treatment of inflammation |
| 09/28/2006 | US20060217444 Tramadol for the treatment of functional gastrointestinal disorders |
| 09/28/2006 | US20060217442 Preventive or ameliorating agent for liver disease involving hepatopathy |
| 09/28/2006 | US20060217434 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs |
| 09/28/2006 | US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor |
| 09/28/2006 | US20060217406 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents |
| 09/28/2006 | US20060217388 Phthalazine derivatives for treating inflammatory diseases |
| 09/28/2006 | US20060217378 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | US20060217349 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |
| 09/28/2006 | US20060217314 Feline hepatocyte growth factor |
| 09/28/2006 | US20060217304 Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders |
| 09/28/2006 | US20060217299 Degradation inhibitor for hepatitis b virus x interacting protein |
| 09/28/2006 | US20060217296 For treatment and/or prevention of loss of body weight and body fat, cachexia, stimulation of appetite, food intake, stimulation of weight gain, and/or increasing body fat mass |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216289 GFRalpha3 and its uses |
| 09/28/2006 | US20060216249 Use of a cosmetic of pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins |
| 09/28/2006 | US20060216245 Composition for local anesthesia |
| 09/28/2006 | DE10015907B4 Verwendung multipartikulärer und multivesikulärer Zubereitungen für die Behandlung von entzündetem Gewebe And use multivesicular multiparticulate preparations for the treatment of inflamed tissue |
| 09/28/2006 | CA2601640A1 Use of macrolides for treating intestinal inflammation |
| 09/28/2006 | CA2601388A1 Thioamide-substituted tricyclic benzimidazoles useful for the treatment of gastrointestinal diseases |
| 09/28/2006 | CA2601381A1 6-thioamide substituted benzimidazoles |
| 09/28/2006 | CA2600773A1 Benzamidine derivatives for treatment and prevention of cancer therapy induced mucositis |
| 09/28/2006 | CA2580857A1 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 09/27/2006 | EP1705487A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 09/27/2006 | EP1705189A1 Feline hepatocyte growth factor |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1704868A1 HLA binding peptides and their uses |
| 09/27/2006 | EP1704865A2 Treatment of C. difficile toxin B associated conditions |
| 09/27/2006 | EP1704862A1 2,5-bis(tetrahydroxybutyl)pyrazines for the treatment of osteoarthritis and rheumatoid arthritis |
| 09/27/2006 | EP1704860A1 Benzamidine derivatives for treatment and prevention of mucositis |
| 09/27/2006 | EP1704146A1 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 09/27/2006 | EP1703918A2 Combination of crf antagonists and 5-ht 1b receptor antagonists |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1501826B1 Substituted indoles as alpha-1 agonists |
| 09/27/2006 | EP1450792B1 Benzazole derivatives for the treatment of scleroderma |
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/27/2006 | EP1286660B1 Pharmaceutical composition in liquid form for oral administration of an active principle, with unpleasant, in particular bitter, taste |
| 09/27/2006 | EP1246622B1 Novel substituted benzimidazole dosage forms and method of using same |
| 09/27/2006 | CN1839149A Peptides which can bind to transforming growth factor beta 1 (tgf-beta1) |
| 09/27/2006 | CN1839127A Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
| 09/27/2006 | CN1837243A Cuttlebone polysaccharide CPS-1 and its preparation and use |